Thomas Niel

Thomas Niel

InvestorPlace Contributor

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

Recent Results Cast Doubt on a ContextLogic Stock Comeback Anytime Soon

By Thomas Niel, InvestorPlace Contributor

Barring another "meme stock" wave, which could give the stock another temporary jolt, WISH stock will likely sell off some more before it jumps back to double-digit prices.

Expect a Slow and Steady Move Lower for GameStop

By Thomas Niel, InvestorPlace Contributor

It may take some time, but it's inevitable that GME stock, the king of meme stocks, falls to a price based on its underlying value.

7 Meme Stocks to Buy That Are Even Better Than Robinhood

By Thomas Niel, InvestorPlace Contributor

So which "meme stocks" appear to be better opportunities than Robinhood? Consider these seven, all trending on Reddit's r/WallStreetBets subreddit, as top ones to buy.

Novavax Stock Could Remain a Winner, Despite its ‘Also Ran’ Status

By Thomas Niel, InvestorPlace Contributor

Its vaccine candidate may not have been first in the running. But now with even more ways for NVAX stock to soar from here, now may be the time to buy.

Ocugen Stock Remains an All or Nothing Wager You Shouldn’t Make

By Thomas Niel, InvestorPlace Contributor

In so many words, the story's unchanged with OCGN stock. An all or nothing bet, with more pointing to "nothing," it's still best to stay away.

Load More